Drug – bio-affecting and body treating compositions – Designated organic active ingredient containing – Ester doai
Patent
1997-03-11
1998-06-02
Fay, Zohreh
Drug, bio-affecting and body treating compositions
Designated organic active ingredient containing
Ester doai
514563, 514912, A61K 3124
Patent
active
057600775
ABSTRACT:
A preparation suitable for sustained and extended corneal analgesia and for repeated administration consisting of ultralow nontoxic subanaesthetic concentrations of local anesthetic agents. A method for corneal analgesia has a fast onset of pain relief and extended duration of the corneal analgesia for several months without accompanying toxic symptoms by administering to a patient an ophthalmic analgesic solution containing a local anesthetic agent in subanesthetic concentration.
REFERENCES:
Steve Arshinoff, M.D., Use of Topical Nonsteroidal Anti-inflammatory Drugs in Excimer Laser Photorefractive Keratectomy, J Cataract Refract Sur, vol. 20, 216-222, (Supplement 1994).
Jean Daniel Arbour, M.D., et al, Should We Patch Corneal Erosions?, Arch Opgthalmol., vol. 115, 313-317, (Mar. 1997).
A K Brahma, et al., Topical Analgesia For Superficial Corneal Injuries, J Accid Emerg Med, 13:186-188, (1996).
Steve A. Arshinoff, M.D., et al., Pharmacotherapy of Photorefractive Keratectomy, J Cataract Refract Sur, vol. 22, 1037-1044 (Oct. 1996).
Fay Zohreh
Verny Hana
LandOfFree
Topical ophthalmic analgesic preparations for sustained and exte does not yet have a rating. At this time, there are no reviews or comments for this patent.
If you have personal experience with Topical ophthalmic analgesic preparations for sustained and exte, we encourage you to share that experience with our LandOfFree.com community. Your opinion is very important and Topical ophthalmic analgesic preparations for sustained and exte will most certainly appreciate the feedback.
Profile ID: LFUS-PAI-O-1460312